Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$9.595 -3.66%
Market Cap
$508.7M
Price Target
Refer to Report
Volume
178.2K
52wk Range
$1.57 - $11.6099
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.